Position in AURA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,777,627
+$364,427 QoQ
Shares Held
415,191
-6.2% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. AURA ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in AURA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,777,627 | 415,191 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,413,200 | 442,789 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,974,006 | 481,231 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,160,223 | 504,828 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,045,939 | 519,785 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,578,054 | 556,941 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,598,682 | 516,126 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,336,717 | 573,640 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,674,988 | 595,540 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,844,870 | 659,692 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $5,893,549 | 657,029 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,219,270 | 665,528 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,594,413 | 710,605 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,761,757 | 739,215 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||